Bisoprolol Fumarate + Hydrochlorothiazide
Generic Details
Generic Name
Bisoprolol-Fumarate-Hydrochlorothiazide
Other Names
- Bisoprolol HCTZ
Drug Class
- Beta-blocker with thiazide diuretic
Chemical Formula
C18H31NO4.C7H8ClN3O4S2
Molecular Weight
681.68 g/mol
Mechanism of Action
- Bisoprolol reduces heart rate and blood pressure by blocking beta receptors. Hydrochlorothiazide promotes diuresis by inhibiting sodium reabsorption.
Indications
- Hypertension
- Congestive heart failure
Common Dosage Forms
- Tablet
Typical Dosage
- 5mg/6.25mg to 10mg/6.25mg once daily
Pediatric Dosage
- Not established
Geriatric Dosage
- Dosage adjustments may be required
Side Effects
- Dizziness
- Fatigue
- Hypotension
- Increased urination
- Electrolyte imbalances
Contraindications
- Bradycardia
- Severe hepatic impairment
- Severe renal impairment
Pregnancy Category
- C - Bisoprolol
- C - Hydrochlorothiazide
Lactation Safety
- Limited data available, caution advised
Drug Interactions
- NSAIDs
- Lithium
- Digitalis glycosides
Overdose Symptoms
- Severe hypotension
- Bradycardia
- Electrolyte abnormalities
Antidote for Overdose
- Intravenous fluids
- Atropine for bradycardia
Storage Conditions
- Store at room temperature away from moisture and heat
Pharmacokinetics
- Absorption: Well absorbed orally
- Distribution: Bisoprolol: Widely distributed, Hydrochlorothiazide: Crosses the placenta and enters breast milk
- Metabolism: Bisoprolol: Hepatic (CYP2D6), Hydrochlorothiazide: Minimal metabolism
- Excretion: Renal
Precautions
- Caution in patients with asthma or COPD due to beta-blocker component
- Monitor electrolytes periodically
Warnings
- May cause fetal harm if used during pregnancy
- Avoid abrupt withdrawal to prevent rebound hypertension
Others
- Combination therapy to address both hypertension and heart failure